An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy

KS Alharbi, MAJ Shaikh, O Afzal, ASA Altamimi… - Chemico-Biological …, 2022 - Elsevier
Epithelial growth factor receptor (EGFR), a transmembrane receptor on the cell surface,
carries extracellular messages into the cell and alters the activity of the nucleus through …

Recent developments and challenges in molecular-targeted therapy of non-small-cell lung cancer

S Rohilla, M Singh, SI Alzarea… - Journal of …, 2023 - dl.begellhouse.com
Treatment of lung cancer with conventional therapies, which include radiation, surgery, and
chemotherapy results in multiple undesirable adverse or side effects. The major clinical …

Janus kinase-signal transducer and activator of transcription inhibitors for the treatment and management of cancer

FA Rizwi, M Abubakar, ER Puppala… - Journal of …, 2023 - dl.begellhouse.com
ABSTRACT According to the World Health Organization (WHO), cancer is the second-
highest cause of mortality worldwide, killing nearly 9.6 million people annually. Despite the …

[引用][C] Janus kinase (JAK)-signal transducer and activator of transcription (STAT) inhibitors for the treatment and management of cancer

FA Rizwi, M Abubakar, ER Puppala, A Goyal… - Journal of … - Begel House Inc.